US6136311A
(en)
*
|
1996-05-06 |
2000-10-24 |
Cornell Research Foundation, Inc. |
Treatment and diagnosis of cancer
|
US7767422B2
(en)
*
|
1998-09-22 |
2010-08-03 |
Oncomedx, Inc. |
Detection of 5T4 RNA in plasma and serum
|
KR20020079364A
(ko)
*
|
1999-06-28 |
2002-10-19 |
소스 프리시전 메디슨, 인코포레이티드 |
보정된 유전자 발현 프로파일을 이용한 생물학적 상태또는 물질을 특성화하기 위한 시스템 및 방법
|
US6586177B1
(en)
*
|
1999-09-08 |
2003-07-01 |
Exact Sciences Corporation |
Methods for disease detection
|
US6919174B1
(en)
*
|
1999-12-07 |
2005-07-19 |
Exact Sciences Corporation |
Methods for disease detection
|
GB0009784D0
(en)
*
|
2000-04-20 |
2000-06-07 |
Simeg Limited |
Methods for clinical diagnosis
|
GB0016742D0
(en)
*
|
2000-07-10 |
2000-08-30 |
Simeg Limited |
Diagnostic method
|
US7083924B2
(en)
|
2000-07-10 |
2006-08-01 |
Btg International Limited |
Diagnostic method for the identification of foetal DNA in a material sample
|
AU2001285157A1
(en)
*
|
2000-08-28 |
2002-03-13 |
Oncomedx, Inc. |
5t4 rna in plasma and serum as a marker for neoplastic disease
|
US6664056B2
(en)
|
2000-10-17 |
2003-12-16 |
The Chinese University Of Hong Kong |
Non-invasive prenatal monitoring
|
US20090226915A1
(en)
*
|
2001-01-24 |
2009-09-10 |
Health Discovery Corporation |
Methods for Screening, Predicting and Monitoring Prostate Cancer
|
WO2002102976A2
(en)
*
|
2001-06-14 |
2002-12-27 |
The Regents Of The University Of California |
Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
|
US6927028B2
(en)
|
2001-08-31 |
2005-08-09 |
Chinese University Of Hong Kong |
Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
|
US20030211522A1
(en)
*
|
2002-01-18 |
2003-11-13 |
Landes Gregory M. |
Methods for fetal DNA detection and allele quantitation
|
AU2003213107A1
(en)
|
2002-02-15 |
2003-09-09 |
Exact Sciences Corporation |
Methods for analysis of molecular events
|
CN1650032A
(zh)
|
2002-03-01 |
2005-08-03 |
拉瓦格恩公司 |
检测遗传疾病的方法
|
US6977162B2
(en)
*
|
2002-03-01 |
2005-12-20 |
Ravgen, Inc. |
Rapid analysis of variations in a genome
|
US7442506B2
(en)
*
|
2002-05-08 |
2008-10-28 |
Ravgen, Inc. |
Methods for detection of genetic disorders
|
US20070178478A1
(en)
*
|
2002-05-08 |
2007-08-02 |
Dhallan Ravinder S |
Methods for detection of genetic disorders
|
US7727720B2
(en)
*
|
2002-05-08 |
2010-06-01 |
Ravgen, Inc. |
Methods for detection of genetic disorders
|
ES2375724T3
(es)
|
2002-09-27 |
2012-03-05 |
The General Hospital Corporation |
Dispositivo microflu�?dico para seperación de células y sus usos.
|
CA2445204C
(en)
|
2002-10-16 |
2014-08-12 |
Streck Laboratories, Inc. |
Method and device for collecting and preserving cells for analysis
|
DE10254601A1
(de)
*
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
EP1581629B1
(de)
*
|
2002-12-06 |
2015-04-01 |
Millennium Pharmaceuticals, Inc. |
Verfahren zur identifizierung,beurteilung und behandlung von patienten mit einer proteasomen inhibitions therapie
|
CN101245376A
(zh)
*
|
2003-01-17 |
2008-08-20 |
香港中文大学 |
作为妊娠相关病症的诊断标志物的循环mRNA
|
EP1664077B1
(de)
*
|
2003-09-05 |
2016-04-13 |
Trustees of Boston University |
Verfahren zur nichtinvasiven pränatalen diagnose
|
ATE435301T1
(de)
*
|
2003-10-16 |
2009-07-15 |
Sequenom Inc |
Nicht invasiver nachweis fötaler genetischer merkmale
|
WO2005043121A2
(en)
*
|
2003-10-31 |
2005-05-12 |
Vitatex, Inc. |
Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
|
WO2005072133A2
(en)
*
|
2004-01-27 |
2005-08-11 |
Zoragen, Inc. |
Nucleic acid detection
|
JP2007526823A
(ja)
|
2004-02-02 |
2007-09-20 |
ザ ユニバーシティ オブ ブリティッシュ コロンビア |
粒子を運動および濃縮させるためのスコダ泳動ならびに方法および装置
|
US10337054B2
(en)
|
2004-02-02 |
2019-07-02 |
Quantum-Si Incorporated |
Enrichment of nucleic acid targets
|
US8529744B2
(en)
|
2004-02-02 |
2013-09-10 |
Boreal Genomics Corp. |
Enrichment of nucleic acid targets
|
US8518228B2
(en)
|
2011-05-20 |
2013-08-27 |
The University Of British Columbia |
Systems and methods for enhanced SCODA
|
US9186685B2
(en)
|
2012-01-13 |
2015-11-17 |
The University Of British Columbia |
Multiple arm apparatus and methods for separation of particles
|
WO2005080570A1
(ja)
*
|
2004-02-24 |
2005-09-01 |
Mitsubishi Rayon Co., Ltd. |
乳癌の術後予後予測に関与する遺伝子
|
US20080241827A1
(en)
*
|
2004-05-10 |
2008-10-02 |
Exact Sciences Corporation |
Methods For Detecting A Mutant Nucleic Acid
|
US7709194B2
(en)
*
|
2004-06-04 |
2010-05-04 |
The Chinese University Of Hong Kong |
Marker for prenatal diagnosis and monitoring
|
WO2006026654A2
(en)
|
2004-08-27 |
2006-03-09 |
Exact Sciences Corporation |
Method for detecting a recombinant event
|
US8024128B2
(en)
*
|
2004-09-07 |
2011-09-20 |
Gene Security Network, Inc. |
System and method for improving clinical decisions by aggregating, validating and analysing genetic and phenotypic data
|
WO2006047787A2
(en)
|
2004-10-27 |
2006-05-04 |
Exact Sciences Corporation |
Method for monitoring disease progression or recurrence
|
US11105808B2
(en)
|
2004-11-12 |
2021-08-31 |
Health Discovery Corporation |
Methods for screening, predicting and monitoring prostate cancer
|
CA2598217A1
(en)
*
|
2005-02-18 |
2006-08-24 |
Marsha A. Moses |
Cyr61 as a biomarker for diagnosis and prognosis of cancers of epithelial origin
|
AU2006228990B8
(en)
*
|
2005-04-01 |
2013-02-07 |
Medvet Science Pty. Ltd. |
A method of diagnosis and treatment and agents useful for same
|
US20070026418A1
(en)
*
|
2005-07-29 |
2007-02-01 |
Martin Fuchs |
Devices and methods for enrichment and alteration of circulating tumor cells and other particles
|
US20070196820A1
(en)
|
2005-04-05 |
2007-08-23 |
Ravi Kapur |
Devices and methods for enrichment and alteration of cells and other particles
|
WO2007044071A2
(en)
|
2005-04-21 |
2007-04-19 |
Exact Sciences Corporation |
Analysis of heterogeneous nucleic acid samples
|
JP2008543277A
(ja)
*
|
2005-05-11 |
2008-12-04 |
ジェネティック テクノロジーズ リミテッド |
胎児細胞を富化する方法
|
WO2007044091A2
(en)
*
|
2005-06-02 |
2007-04-19 |
Fluidigm Corporation |
Analysis using microfluidic partitioning devices
|
US20070027636A1
(en)
*
|
2005-07-29 |
2007-02-01 |
Matthew Rabinowitz |
System and method for using genetic, phentoypic and clinical data to make predictions for clinical or lifestyle decisions
|
US8532930B2
(en)
|
2005-11-26 |
2013-09-10 |
Natera, Inc. |
Method for determining the number of copies of a chromosome in the genome of a target individual using genetic data from genetically related individuals
|
US11111543B2
(en)
|
2005-07-29 |
2021-09-07 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
US8921102B2
(en)
|
2005-07-29 |
2014-12-30 |
Gpb Scientific, Llc |
Devices and methods for enrichment and alteration of circulating tumor cells and other particles
|
US9424392B2
(en)
|
2005-11-26 |
2016-08-23 |
Natera, Inc. |
System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
|
US10083273B2
(en)
|
2005-07-29 |
2018-09-25 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
US8515679B2
(en)
*
|
2005-12-06 |
2013-08-20 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
US11111544B2
(en)
|
2005-07-29 |
2021-09-07 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
US10081839B2
(en)
|
2005-07-29 |
2018-09-25 |
Natera, Inc |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
US20070178501A1
(en)
*
|
2005-12-06 |
2007-08-02 |
Matthew Rabinowitz |
System and method for integrating and validating genotypic, phenotypic and medical information into a database according to a standardized ontology
|
US7888017B2
(en)
*
|
2006-02-02 |
2011-02-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Non-invasive fetal genetic screening by digital analysis
|
US8609338B2
(en)
|
2006-02-28 |
2013-12-17 |
University Of Louisville Research Foundation, Inc. |
Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms
|
ATE508209T1
(de)
*
|
2006-02-28 |
2011-05-15 |
Univ Louisville Res Found |
Erkennung von chromosomabnormalitäten im fötus mit hilfe der tandem-einzelnukleotid- polymorphismen
|
US7754428B2
(en)
|
2006-05-03 |
2010-07-13 |
The Chinese University Of Hong Kong |
Fetal methylation markers
|
US7901884B2
(en)
|
2006-05-03 |
2011-03-08 |
The Chinese University Of Hong Kong |
Markers for prenatal diagnosis and monitoring
|
US20080050739A1
(en)
|
2006-06-14 |
2008-02-28 |
Roland Stoughton |
Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
|
US20080070792A1
(en)
|
2006-06-14 |
2008-03-20 |
Roland Stoughton |
Use of highly parallel snp genotyping for fetal diagnosis
|
EP2589668A1
(de)
|
2006-06-14 |
2013-05-08 |
Verinata Health, Inc |
Analyse seltener Zellen mittels Probentrennung und DNA-Etiketten
|
US8137912B2
(en)
|
2006-06-14 |
2012-03-20 |
The General Hospital Corporation |
Methods for the diagnosis of fetal abnormalities
|
CN106970220A
(zh)
*
|
2006-08-03 |
2017-07-21 |
国立大学法人东京大学 |
天然形式人自分泌运动因子特异的抗体、其筛选方法以及检测试剂
|
GB0616045D0
(en)
*
|
2006-08-11 |
2006-09-20 |
Univ Bristol |
Blood cell separation
|
TWI335354B
(en)
|
2006-09-27 |
2011-01-01 |
Univ Hong Kong Chinese |
Methods for the detection of the degree of the methylation of a target dna and kits
|
US7902345B2
(en)
|
2006-12-05 |
2011-03-08 |
Sequenom, Inc. |
Detection and quantification of biomolecules using mass spectrometry
|
WO2008117067A2
(en)
|
2007-03-27 |
2008-10-02 |
Carl Arne Krister Borrebaeck |
Protein signature/markers for the detection of adenocarcinoma
|
EP2147309A4
(de)
*
|
2007-05-05 |
2010-08-04 |
Univ Western Ontario |
Verfahren für den nachweis von präeklampsie
|
US20100297067A1
(en)
*
|
2007-05-14 |
2010-11-25 |
The Johns Hopkins University |
Methylation markers for prostate cancer and methods of use
|
PT2557517T
(pt)
*
|
2007-07-23 |
2023-01-04 |
Univ Hong Kong Chinese |
Determinação de um desequilíbrio de sequências de ácido nucleico
|
US20100112590A1
(en)
|
2007-07-23 |
2010-05-06 |
The Chinese University Of Hong Kong |
Diagnosing Fetal Chromosomal Aneuploidy Using Genomic Sequencing With Enrichment
|
US9404150B2
(en)
|
2007-08-29 |
2016-08-02 |
Sequenom, Inc. |
Methods and compositions for universal size-specific PCR
|
AU2009205956B2
(en)
|
2008-01-18 |
2015-07-02 |
President And Fellows Of Harvard College |
Methods of detecting signatures of disease or conditions in bodily fluids
|
US8475641B2
(en)
|
2008-02-01 |
2013-07-02 |
The University Of British Columbia |
Methods and apparatus for particle introduction and recovery
|
CN101999003A
(zh)
*
|
2008-02-12 |
2011-03-30 |
诺瓦蒂斯公司 |
分离无细胞凋亡或胎儿核酸的方法
|
US20110033862A1
(en)
*
|
2008-02-19 |
2011-02-10 |
Gene Security Network, Inc. |
Methods for cell genotyping
|
EP2863220B1
(de)
*
|
2008-03-11 |
2017-09-06 |
Urobiologics LLC |
Reduktions-/Oxidationsaktivität von mütterlichem Harn als Indikator von geschlechtsspezifischen Merkmalen des Fötus
|
EP2271772B1
(de)
*
|
2008-03-11 |
2014-07-16 |
Sequenom, Inc. |
Tests auf nukleinsäurebasis zur pränatalen geschlechtsbestimmung
|
US10996218B2
(en)
|
2008-03-11 |
2021-05-04 |
Ournextbaby Llc |
Methods for chemotaxis / redox driven separation of X and Y chromosome bearing sperm and their insemination in gender specific menstrual cycles
|
WO2009146335A1
(en)
*
|
2008-05-27 |
2009-12-03 |
Gene Security Network, Inc. |
Methods for embryo characterization and comparison
|
CA2731991C
(en)
|
2008-08-04 |
2021-06-08 |
Gene Security Network, Inc. |
Methods for allele calling and ploidy calling
|
AU2009293232B2
(en)
|
2008-09-16 |
2015-05-14 |
Sequenom Center For Molecular Medicine |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
SI2334812T1
(sl)
|
2008-09-20 |
2017-05-31 |
The Board of Trustees of the Leland Stanford Junior University Office of the General Counsel Building 170 |
Neinvazivna diagnoza fetalne anevploidije s sekvenciranjem
|
US9127312B2
(en)
|
2011-02-09 |
2015-09-08 |
Bio-Rad Laboratories, Inc. |
Analysis of nucleic acids
|
US9528160B2
(en)
|
2008-11-07 |
2016-12-27 |
Adaptive Biotechnolgies Corp. |
Rare clonotypes and uses thereof
|
US9506119B2
(en)
|
2008-11-07 |
2016-11-29 |
Adaptive Biotechnologies Corp. |
Method of sequence determination using sequence tags
|
US8628927B2
(en)
|
2008-11-07 |
2014-01-14 |
Sequenta, Inc. |
Monitoring health and disease status using clonotype profiles
|
US8748103B2
(en)
|
2008-11-07 |
2014-06-10 |
Sequenta, Inc. |
Monitoring health and disease status using clonotype profiles
|
US9365901B2
(en)
|
2008-11-07 |
2016-06-14 |
Adaptive Biotechnologies Corp. |
Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
|
GB2467704B
(en)
|
2008-11-07 |
2011-08-24 |
Mlc Dx Inc |
A method for determining a profile of recombined DNA sequences in T-cells and/or B-cells
|
WO2010078194A1
(en)
*
|
2008-12-30 |
2010-07-08 |
Streck, Inc. |
Method for screening blood using a preservative that may be in a substantially solid state form
|
PT2387627E
(pt)
|
2009-01-15 |
2016-06-03 |
Adaptive Biotechnologies Corp |
Determinação do perfil de imunidade adaptativa e métodos de geração de anticorpos monoclonais
|
DE202010018561U1
(de)
|
2009-01-21 |
2017-08-28 |
Streck Inc. |
Blutsammelröhrchen
|
US11634747B2
(en)
|
2009-01-21 |
2023-04-25 |
Streck Llc |
Preservation of fetal nucleic acids in maternal plasma
|
CA2751679C
(en)
|
2009-02-06 |
2018-02-27 |
Women & Infants' Hospital Of Rhode Island |
Compositions for treating preeclampsia-type disorders of pregnancy comprising transthyretin
|
EP3290530B1
(de)
|
2009-02-18 |
2020-09-02 |
Streck Inc. |
Konservierung von zellfreien nukleinsäuren
|
CA2755615A1
(en)
*
|
2009-03-18 |
2010-09-23 |
Sequenom, Inc. |
Use of thermostable endonucleases for generating reporter molecules
|
US9447467B2
(en)
|
2009-04-21 |
2016-09-20 |
Genetic Technologies Limited |
Methods for obtaining fetal genetic material
|
US8877028B2
(en)
|
2009-04-21 |
2014-11-04 |
The University Of British Columbia |
System and methods for detection of particles
|
WO2010123625A1
(en)
|
2009-04-24 |
2010-10-28 |
University Of Southern California |
Cd133 polymorphisms predict clinical outcome in patients with cancer
|
US20100330571A1
(en)
|
2009-06-25 |
2010-12-30 |
Robins Harlan S |
Method of measuring adaptive immunity
|
KR101117916B1
(ko)
|
2009-07-30 |
2012-02-24 |
삼성메디슨 주식회사 |
새지털 뷰를 검출하는 초음파 시스템 및 방법
|
US20110070590A1
(en)
*
|
2009-09-22 |
2011-03-24 |
Jan Rohozinski |
Primers and Methods for Determining RhD Zygosity
|
EP2473638B1
(de)
|
2009-09-30 |
2017-08-09 |
Natera, Inc. |
Verfahren zur nichtinvasiven pränatalen ploidiezuordnung
|
RS63944B1
(sr)
|
2009-11-05 |
2023-02-28 |
Univ Hong Kong Chinese |
Analiza genoma fetusa iz biološkog uzorka majke
|
CA2779750C
(en)
|
2009-11-06 |
2019-03-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Non-invasive diagnosis of graft rejection in organ transplant patients
|
ES2571104T3
(es)
*
|
2009-11-09 |
2016-05-24 |
Streck Inc |
Estabilización del ARN y extracción del ARN presente en células intactas dentro de una muestra de sangre
|
WO2011066476A1
(en)
*
|
2009-11-25 |
2011-06-03 |
Quantalife, Inc. |
Methods and compositions for detecting genetic material
|
GB0921873D0
(en)
*
|
2009-12-15 |
2010-01-27 |
Cytosystems Ltd |
Assay
|
WO2011084757A1
(en)
|
2009-12-21 |
2011-07-14 |
University Of Southern California |
Germline polymorphisms in the sparc gene associated with clinical outcome in gastric cancer
|
WO2011087760A2
(en)
|
2009-12-22 |
2011-07-21 |
Sequenom, Inc. |
Processes and kits for identifying aneuploidy
|
EP2516677B1
(de)
|
2009-12-23 |
2014-11-26 |
Genetic Technologies Limited |
Verfahren zur anreicherung und detektion fetaler nucleinsäuren
|
WO2011085334A1
(en)
|
2010-01-11 |
2011-07-14 |
University Of Southern California |
Cd44 polymorphisms predict clinical outcome in patients with gastric cancer
|
US10388403B2
(en)
|
2010-01-19 |
2019-08-20 |
Verinata Health, Inc. |
Analyzing copy number variation in the detection of cancer
|
EP2366031B1
(de)
*
|
2010-01-19 |
2015-01-21 |
Verinata Health, Inc |
Sequenzierungsverfahren in pränatale diagnosen
|
WO2011090556A1
(en)
|
2010-01-19 |
2011-07-28 |
Verinata Health, Inc. |
Methods for determining fraction of fetal nucleic acid in maternal samples
|
US9323888B2
(en)
|
2010-01-19 |
2016-04-26 |
Verinata Health, Inc. |
Detecting and classifying copy number variation
|
US20120100548A1
(en)
|
2010-10-26 |
2012-04-26 |
Verinata Health, Inc. |
Method for determining copy number variations
|
US9260745B2
(en)
|
2010-01-19 |
2016-02-16 |
Verinata Health, Inc. |
Detecting and classifying copy number variation
|
US8700341B2
(en)
|
2010-01-19 |
2014-04-15 |
Verinata Health, Inc. |
Partition defined detection methods
|
WO2011091046A1
(en)
|
2010-01-19 |
2011-07-28 |
Verinata Health, Inc. |
Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing
|
US20110312503A1
(en)
|
2010-01-23 |
2011-12-22 |
Artemis Health, Inc. |
Methods of fetal abnormality detection
|
KR101533469B1
(ko)
*
|
2010-02-03 |
2015-07-02 |
연세대학교 산학협력단 |
Ras의 Thr-144번과 Thr-148번의 인산화의 감지를 통한 암 진단 방법, 항암제 스크리닝 및 약효테스트 방법
|
US8774488B2
(en)
|
2010-03-11 |
2014-07-08 |
Cellscape Corporation |
Method and device for identification of nucleated red blood cells from a maternal blood sample
|
US11332793B2
(en)
|
2010-05-18 |
2022-05-17 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
US20190010543A1
(en)
|
2010-05-18 |
2019-01-10 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
US10316362B2
(en)
|
2010-05-18 |
2019-06-11 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
US11322224B2
(en)
|
2010-05-18 |
2022-05-03 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
US11339429B2
(en)
|
2010-05-18 |
2022-05-24 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
US11326208B2
(en)
|
2010-05-18 |
2022-05-10 |
Natera, Inc. |
Methods for nested PCR amplification of cell-free DNA
|
US11408031B2
(en)
|
2010-05-18 |
2022-08-09 |
Natera, Inc. |
Methods for non-invasive prenatal paternity testing
|
US11332785B2
(en)
|
2010-05-18 |
2022-05-17 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
US11939634B2
(en)
|
2010-05-18 |
2024-03-26 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
WO2011146632A1
(en)
|
2010-05-18 |
2011-11-24 |
Gene Security Network Inc. |
Methods for non-invasive prenatal ploidy calling
|
US9677118B2
(en)
|
2014-04-21 |
2017-06-13 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
WO2012012717A1
(en)
|
2010-07-23 |
2012-01-26 |
President And Fellows Of Harvard College |
Methods of detecting prenatal or pregnancy-related diseases or conditions
|
US20120053073A1
(en)
|
2010-07-23 |
2012-03-01 |
President And Fellows Of Harvard College |
Methods for Detecting Signatures of Disease or Conditions in Bodily Fluids
|
EP2596116A4
(de)
|
2010-07-23 |
2014-03-19 |
Harvard College |
Verfahren zur erkennung von autoimmun- oder autoimmunbezogenen erkrankungen oder leiden
|
CN103124795A
(zh)
|
2010-07-23 |
2013-05-29 |
哈佛大学校长及研究员协会 |
利用吞噬细胞检测疾病或病症的方法
|
US9804163B2
(en)
*
|
2010-08-06 |
2017-10-31 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Biomarkers for prostate cancer and methods for their detection
|
US20120034603A1
(en)
|
2010-08-06 |
2012-02-09 |
Tandem Diagnostics, Inc. |
Ligation-based detection of genetic variants
|
US8700338B2
(en)
|
2011-01-25 |
2014-04-15 |
Ariosa Diagnosis, Inc. |
Risk calculation for evaluation of fetal aneuploidy
|
US10167508B2
(en)
|
2010-08-06 |
2019-01-01 |
Ariosa Diagnostics, Inc. |
Detection of genetic abnormalities
|
US10533223B2
(en)
|
2010-08-06 |
2020-01-14 |
Ariosa Diagnostics, Inc. |
Detection of target nucleic acids using hybridization
|
US20130040375A1
(en)
|
2011-08-08 |
2013-02-14 |
Tandem Diagnotics, Inc. |
Assay systems for genetic analysis
|
US20140342940A1
(en)
|
2011-01-25 |
2014-11-20 |
Ariosa Diagnostics, Inc. |
Detection of Target Nucleic Acids using Hybridization
|
US20130261003A1
(en)
|
2010-08-06 |
2013-10-03 |
Ariosa Diagnostics, In. |
Ligation-based detection of genetic variants
|
US11031095B2
(en)
|
2010-08-06 |
2021-06-08 |
Ariosa Diagnostics, Inc. |
Assay systems for determination of fetal copy number variation
|
US11203786B2
(en)
|
2010-08-06 |
2021-12-21 |
Ariosa Diagnostics, Inc. |
Detection of target nucleic acids using hybridization
|
CN103228796B
(zh)
|
2010-08-11 |
2016-06-01 |
赛路拉公司 |
基因分型dna
|
WO2012036691A1
(en)
|
2010-09-16 |
2012-03-22 |
Urobiologics Llc |
Use of female mammal's urine for determination of fetal gender related characteristics
|
WO2012058316A1
(en)
|
2010-10-26 |
2012-05-03 |
Stanford University |
Non-invasive fetal genetic screening by sequencing analysis
|
CL2010001419A1
(es)
*
|
2010-12-10 |
2011-04-25 |
Aquainnovo S A |
Metodo para detectar el sexo de forma prenatal en el plasma de madre, mediante el uso de la reaccion de polimerasa en cadena (pcr) humano en tiempo real.
|
JP6328934B2
(ja)
|
2010-12-22 |
2018-05-23 |
ナテラ, インコーポレイテッド |
非侵襲性出生前親子鑑定法
|
JP6105485B2
(ja)
*
|
2011-01-05 |
2017-04-05 |
ザ・チャイニーズ・ユニバーシティー・オブ・ホンコンThe Chinese University Of Hong Kong |
胎児の性染色体遺伝子型の非侵襲的出生前同定
|
US9994897B2
(en)
|
2013-03-08 |
2018-06-12 |
Ariosa Diagnostics, Inc. |
Non-invasive fetal sex determination
|
US11270781B2
(en)
|
2011-01-25 |
2022-03-08 |
Ariosa Diagnostics, Inc. |
Statistical analysis for non-invasive sex chromosome aneuploidy determination
|
US10131947B2
(en)
|
2011-01-25 |
2018-11-20 |
Ariosa Diagnostics, Inc. |
Noninvasive detection of fetal aneuploidy in egg donor pregnancies
|
US8756020B2
(en)
|
2011-01-25 |
2014-06-17 |
Ariosa Diagnostics, Inc. |
Enhanced risk probabilities using biomolecule estimations
|
AU2011358564B9
(en)
|
2011-02-09 |
2017-07-13 |
Natera, Inc |
Methods for non-invasive prenatal ploidy calling
|
CN103492589B
(zh)
|
2011-02-24 |
2016-06-15 |
香港中文大学 |
多胎妊娠的分子测试
|
CN103430027B
(zh)
*
|
2011-03-11 |
2015-05-20 |
霍夫曼-拉罗奇有限公司 |
Apex1作为慢性阻塞性肺病(copd)的标志物
|
JP5976694B2
(ja)
*
|
2011-03-11 |
2016-08-24 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
慢性閉塞性肺疾患(copd)のマーカーとしてのnnmt
|
HUE050032T2
(hu)
|
2011-04-12 |
2020-11-30 |
Verinata Health Inc |
Genomfrakciók feloldása polimorfizmus-szám alkalmazásával
|
US9411937B2
(en)
|
2011-04-15 |
2016-08-09 |
Verinata Health, Inc. |
Detecting and classifying copy number variation
|
JP2014513949A
(ja)
*
|
2011-04-20 |
2014-06-19 |
トラクソン・リミテッド・ライアビリティ・カンパニー |
患者における癌の診断方法
|
US20140234860A1
(en)
*
|
2011-04-20 |
2014-08-21 |
Traxxsson, Llc |
Measurement of pka for cancer characterization
|
EP3378954B1
(de)
|
2011-04-29 |
2021-02-17 |
Sequenom, Inc. |
Quantifizierung einer minderheitsvariante einer nukleinsäure
|
WO2012151391A2
(en)
|
2011-05-04 |
2012-11-08 |
Streck, Inc. |
Inactivated virus compositions and methods of preparing such compositions
|
WO2012177792A2
(en)
|
2011-06-24 |
2012-12-27 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of a genetic variation
|
SG191757A1
(en)
|
2011-06-29 |
2013-08-30 |
Bgi Health Service Co Ltd |
Noninvasive detection of fetal genetic abnormality
|
US20130018700A1
(en)
*
|
2011-07-14 |
2013-01-17 |
International Business Machines Corporation |
Optimizing product portfolios under customer choice
|
EP2732053B1
(de)
|
2011-07-14 |
2017-10-25 |
Progenity, Inc. |
Systeme, vorrichtungen und verfahren für biochemische analysen
|
EP2738252B1
(de)
*
|
2011-07-26 |
2019-07-10 |
National Institute of Advanced Industrial Science And Technology |
Antikörper zum nachweis von markern für epithelialen eierstockkrebs und verfahren zur diagnose von epithelialem eierstockkrebs
|
US8712697B2
(en)
|
2011-09-07 |
2014-04-29 |
Ariosa Diagnostics, Inc. |
Determination of copy number variations using binomial probability calculations
|
US10385475B2
(en)
|
2011-09-12 |
2019-08-20 |
Adaptive Biotechnologies Corp. |
Random array sequencing of low-complexity libraries
|
JP6276992B2
(ja)
*
|
2011-09-15 |
2018-02-14 |
国立大学法人名古屋大学 |
胸膜中皮腫患者の早期発見のための分子マーカー及びその発現解析方法
|
US10196681B2
(en)
|
2011-10-06 |
2019-02-05 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
US9984198B2
(en)
|
2011-10-06 |
2018-05-29 |
Sequenom, Inc. |
Reducing sequence read count error in assessment of complex genetic variations
|
US10424394B2
(en)
|
2011-10-06 |
2019-09-24 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
WO2013052907A2
(en)
|
2011-10-06 |
2013-04-11 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
US9367663B2
(en)
|
2011-10-06 |
2016-06-14 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
US8688388B2
(en)
|
2011-10-11 |
2014-04-01 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
ES2651612T3
(es)
|
2011-10-18 |
2018-01-29 |
Multiplicom Nv |
Diagnóstico de aneuploidía cromosómica fetal
|
CA2853088C
(en)
|
2011-10-21 |
2018-03-13 |
Adaptive Biotechnologies Corporation |
Quantification of adaptive immune cell genomes in a complex mixture of cells
|
AU2012347460B2
(en)
|
2011-12-09 |
2017-05-25 |
Adaptive Biotechnologies Corporation |
Diagnosis of lymphoid malignancies and minimal residual disease detection
|
US9499865B2
(en)
|
2011-12-13 |
2016-11-22 |
Adaptive Biotechnologies Corp. |
Detection and measurement of tissue-infiltrating lymphocytes
|
WO2013110007A1
(en)
*
|
2012-01-18 |
2013-07-25 |
The Trustees Of Columbia University In The City Of New York |
USE OF FATOSTATIN FOR TREATING CANCER HAVING A p53 MUTATION
|
ES2929923T3
(es)
|
2012-01-20 |
2022-12-02 |
Sequenom Inc |
Procesos de diagnóstico que condicionan las condiciones experimentales
|
EP2805166B1
(de)
*
|
2012-01-20 |
2018-11-21 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Verfahren zur vorhersage der überlebenszeit eines patienten, der an krebs leidet
|
US9238836B2
(en)
|
2012-03-30 |
2016-01-19 |
Pacific Biosciences Of California, Inc. |
Methods and compositions for sequencing modified nucleic acids
|
KR101256206B1
(ko)
*
|
2012-03-02 |
2013-04-19 |
의료법인 제일의료재단 |
태아의 성별 결정을 위한 분석방법 및 장치
|
EP4155401A1
(de)
|
2012-03-02 |
2023-03-29 |
Sequenom, Inc. |
Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
|
US10077478B2
(en)
|
2012-03-05 |
2018-09-18 |
Adaptive Biotechnologies Corp. |
Determining paired immune receptor chains from frequency matched subunits
|
US20150072349A1
(en)
*
|
2012-03-16 |
2015-03-12 |
University Health Network |
Cancer Biomarkers and Methods of Use
|
EP4239081A3
(de)
|
2012-03-26 |
2023-11-08 |
The Johns Hopkins University |
Schneller nachweis von aneuploidie
|
EP2844773B1
(de)
|
2012-05-04 |
2017-08-16 |
Boreal Genomics Corp. |
Biomarkeranalyse mittels scodaphorese
|
SG11201407107VA
(en)
|
2012-05-08 |
2014-11-27 |
Adaptive Biotechnologies Corp |
Compositions and method for measuring and calibrating amplification bias in multiplexed pcr reactions
|
EP2847592A4
(de)
*
|
2012-05-10 |
2016-05-04 |
Eutropics Pharmaceuticals Inc |
Surrogatfunktionsdiagnosetest für krebs
|
US10289800B2
(en)
|
2012-05-21 |
2019-05-14 |
Ariosa Diagnostics, Inc. |
Processes for calculating phased fetal genomic sequences
|
EP2852682B1
(de)
|
2012-05-21 |
2017-10-04 |
Fluidigm Corporation |
Einzelpartikelanalyse von teilchenpopulationen
|
US10504613B2
(en)
|
2012-12-20 |
2019-12-10 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
US20150150869A1
(en)
|
2012-06-20 |
2015-06-04 |
Eutropics Pharmaceuticals, Inc. |
Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives
|
US10497461B2
(en)
|
2012-06-22 |
2019-12-03 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
CA2878979C
(en)
|
2012-07-13 |
2021-09-14 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
FR2993668B1
(fr)
*
|
2012-07-17 |
2015-07-03 |
Cisbio Bioassays |
Methode theranostique basee sur la detection de dimeres her2-her2
|
CN104583421A
(zh)
|
2012-07-19 |
2015-04-29 |
阿瑞奥萨诊断公司 |
遗传变体的基于多重的顺序连接的检测
|
AU2013327423B2
(en)
|
2012-10-01 |
2017-06-22 |
Adaptive Biotechnologies Corporation |
Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization
|
EP2904534B1
(de)
|
2012-10-04 |
2021-12-15 |
Sequenom, Inc. |
Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
|
US10482994B2
(en)
|
2012-10-04 |
2019-11-19 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
CN104797937A
(zh)
*
|
2012-10-12 |
2015-07-22 |
国立大学法人弘前大学 |
用于识别前列腺癌和前列腺肥大的方法及试剂盒
|
EP2912466B1
(de)
*
|
2012-10-26 |
2018-08-29 |
Institut Gustave Roussy |
Verfahren zur vorhersage der empfindlichkeit eines subjekts auf therapie mit t-zell aktivierenden antikörpern
|
WO2014081953A1
(en)
|
2012-11-21 |
2014-05-30 |
Richard David J |
Methods and compositions useful for treating diseases involving bcl-2 family proteins with isoquinoline and quinoline derivatives
|
US10132810B2
(en)
*
|
2012-11-28 |
2018-11-20 |
Nektar Therapeutics |
Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase I inhibitor
|
US20130309666A1
(en)
|
2013-01-25 |
2013-11-21 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
EP2759602A1
(de)
|
2013-01-25 |
2014-07-30 |
Charité - Universitätsmedizin Berlin |
Nichtinvasive Verfahren zur pränatalen Gendiagnose
|
US20140222512A1
(en)
*
|
2013-02-01 |
2014-08-07 |
Goodsnitch, Inc. |
Receiving, tracking and analyzing business intelligence data
|
US10126301B2
(en)
*
|
2013-02-08 |
2018-11-13 |
Institute For Myeloma & Bone Cancer Research |
Diagnostic, prognostic, and monitoring methods for multiple myeloma, chronic lymphocytic leukemia, and B-cell non-hodgkin lymphoma
|
US11585814B2
(en)
|
2013-03-09 |
2023-02-21 |
Immunis.Ai, Inc. |
Methods of detecting prostate cancer
|
NZ771629A
(en)
|
2013-03-09 |
2022-12-23 |
Harry Stylli |
Methods of detecting cancer
|
WO2014168711A1
(en)
|
2013-03-13 |
2014-10-16 |
Sequenom, Inc. |
Primers for dna methylation analysis
|
GB201304810D0
(en)
|
2013-03-15 |
2013-05-01 |
Isis Innovation |
Assay
|
CN105189748B
(zh)
|
2013-03-15 |
2021-06-08 |
血统生物科学公司 |
测序免疫组库的方法
|
US9340835B2
(en)
|
2013-03-15 |
2016-05-17 |
Boreal Genomics Corp. |
Method for separating homoduplexed and heteroduplexed nucleic acids
|
CN105121660B
(zh)
|
2013-03-15 |
2018-09-28 |
香港中文大学 |
确定多胎妊娠的胎儿基因组
|
ES2939547T3
(es)
|
2013-04-03 |
2023-04-24 |
Sequenom Inc |
Métodos y procedimientos para la evaluación no invasiva de variaciones genéticas
|
TWI522367B
(zh)
*
|
2013-04-12 |
2016-02-21 |
Univ Chang Gung |
Urine biomarkers are used to predict bladder and kidney cancer
|
EP2986326B1
(de)
*
|
2013-04-15 |
2018-09-05 |
Cedars-Sinai Medical Center |
Verfahren zum nachweis von krebsmetastasen
|
CA2909479A1
(en)
|
2013-05-09 |
2014-11-13 |
F. Hoffmann-La Roche Ag |
Method of determining the fraction of fetal dna in maternal blood using hla markers
|
US20140343982A1
(en)
*
|
2013-05-14 |
2014-11-20 |
Landmark Graphics Corporation |
Methods and systems related to workflow mentoring
|
CA2912526C
(en)
*
|
2013-05-16 |
2021-09-14 |
Kyoto University |
Method for determining prognosis of cancer
|
US9725494B2
(en)
*
|
2013-05-17 |
2017-08-08 |
United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Soluble CD27 (sCD27) and the use thereof
|
WO2014190286A2
(en)
|
2013-05-24 |
2014-11-27 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
EP3004888A1
(de)
*
|
2013-05-31 |
2016-04-13 |
Nektar Therapeutics |
Verfahren zur vorhersage und auswertung des ansprechens auf eine krebsbehandlung mit dna-schädigenden chemotherapeutika
|
ES2721051T3
(es)
|
2013-06-21 |
2019-07-26 |
Sequenom Inc |
Método para la evaluación no invasiva de variaciones genéticas
|
US9708657B2
(en)
|
2013-07-01 |
2017-07-18 |
Adaptive Biotechnologies Corp. |
Method for generating clonotype profiles using sequence tags
|
FR3008096B1
(fr)
*
|
2013-07-03 |
2015-08-14 |
Gregory Raux |
Kit et methode de detection in vitro du rhesus d
|
WO2015013244A1
(en)
|
2013-07-24 |
2015-01-29 |
Streck, Inc. |
Compositions and methods for stabilizing circulating tumor cells
|
US10732182B2
(en)
|
2013-08-01 |
2020-08-04 |
Eutropics Pharmaceuticals, Inc. |
Method for predicting cancer sensitivity
|
US10577655B2
(en)
|
2013-09-27 |
2020-03-03 |
Natera, Inc. |
Cell free DNA diagnostic testing standards
|
WO2015048535A1
(en)
|
2013-09-27 |
2015-04-02 |
Natera, Inc. |
Prenatal diagnostic resting standards
|
US10262755B2
(en)
|
2014-04-21 |
2019-04-16 |
Natera, Inc. |
Detecting cancer mutations and aneuploidy in chromosomal segments
|
BR112016007401B1
(pt)
|
2013-10-04 |
2023-04-11 |
Sequenom, Inc. |
Método para determinar a presença ou ausência de uma aneuploidia cromossômica em uma amostra
|
US10438691B2
(en)
|
2013-10-07 |
2019-10-08 |
Sequenom, Inc. |
Non-invasive assessment of chromosome alterations using change in subsequence mappability
|
JP6538044B2
(ja)
|
2013-10-30 |
2019-07-03 |
ユートロピクス ファーマシューティカルズ, インコーポレイテッド |
化学療法感受性および化学毒性を判定する方法
|
IL285106B
(en)
|
2013-11-07 |
2022-09-01 |
Univ Leland Stanford Junior |
Clean nucleic acids are suitable for analyzing the human microbiome and its parts
|
EP2876442A1
(de)
*
|
2013-11-22 |
2015-05-27 |
Institut de Cancérologie de l'Ouest |
Olfactomedin-4, Neudesin und Desmoplakin als Biomarker von Brustkrebs
|
US20160304968A1
(en)
*
|
2013-12-02 |
2016-10-20 |
Oncomed Pharmaceuticals, Inc. |
Identification of Predictive Biomarkers Associated With WNT Pathway Inhibitors
|
AU2015227054A1
(en)
|
2014-03-05 |
2016-09-22 |
Adaptive Biotechnologies Corporation |
Methods using randomer-containing synthetic molecules
|
EP3117011B1
(de)
|
2014-03-13 |
2020-05-06 |
Sequenom, Inc. |
Verfahren und prozesse zur nicht-invasiven beurteilung genetischer variationen
|
US10066265B2
(en)
|
2014-04-01 |
2018-09-04 |
Adaptive Biotechnologies Corp. |
Determining antigen-specific t-cells
|
EP3132059B1
(de)
|
2014-04-17 |
2020-01-08 |
Adaptive Biotechnologies Corporation |
Quantifizierung von adaptiven immunzellgenomen in einer komplexen mischung von zellen
|
CN113774132A
(zh)
|
2014-04-21 |
2021-12-10 |
纳特拉公司 |
检测染色体片段中的突变和倍性
|
US10133996B2
(en)
*
|
2014-04-22 |
2018-11-20 |
International Business Machines Corporation |
Object lifecycle analysis tool
|
US11783911B2
(en)
|
2014-07-30 |
2023-10-10 |
Sequenom, Inc |
Methods and processes for non-invasive assessment of genetic variations
|
EP3693742B1
(de)
|
2014-09-11 |
2022-04-06 |
Harry Stylli |
Verfahren zum nachweis von prostatakrebs
|
WO2016069886A1
(en)
|
2014-10-29 |
2016-05-06 |
Adaptive Biotechnologies Corporation |
Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
|
US10246701B2
(en)
|
2014-11-14 |
2019-04-02 |
Adaptive Biotechnologies Corp. |
Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
|
CA2974240A1
(en)
|
2015-01-12 |
2016-07-21 |
Eutropics Pharmaceuticals, Inc. |
Context dependent diagnostics test for guiding cancer treatment
|
US10364467B2
(en)
|
2015-01-13 |
2019-07-30 |
The Chinese University Of Hong Kong |
Using size and number aberrations in plasma DNA for detecting cancer
|
US11168351B2
(en)
|
2015-03-05 |
2021-11-09 |
Streck, Inc. |
Stabilization of nucleic acids in urine
|
MX2017013383A
(es)
|
2015-04-20 |
2017-12-07 |
Tolero Pharmaceuticals Inc |
Prediccion de respuesta a alvocidib mediante perfilado mitocondrial.
|
US11479812B2
(en)
|
2015-05-11 |
2022-10-25 |
Natera, Inc. |
Methods and compositions for determining ploidy
|
KR102608921B1
(ko)
|
2015-05-18 |
2023-12-01 |
스미토모 파마 온콜로지, 인크. |
생체 이용률이 증가된 알보시딥 프로드러그
|
WO2016185284A1
(en)
|
2015-05-20 |
2016-11-24 |
Boreal Genomics, Inc. |
Method for isolating target nucleic acid using heteroduplex binding proteins
|
WO2016189388A1
(en)
|
2015-05-22 |
2016-12-01 |
Nipd Genetics Ltd |
Multiplexed parallel analysis of targeted genomic regions for non-invasive prenatal testing
|
DE102015111329B4
(de)
|
2015-07-13 |
2017-02-02 |
Bernd-Peter Ernst |
Verfahren zum Bestimmen einer relativen Häufigkeit von verschiedenen Genen oder Chromosomen eines Genoms in einer Probe
|
MX2018001289A
(es)
|
2015-08-03 |
2018-04-30 |
Tolero Pharmaceuticals Inc |
Terapias de combinacion para el tratamiento del cancer.
|
NZ757571A
(en)
|
2015-10-16 |
2023-03-31 |
Inguran Llc |
Methods of genomic evaluation in livestock
|
US11377687B2
(en)
|
2015-10-16 |
2022-07-05 |
Inguran, Llc |
Methods of genomic evaluation in livestock
|
US20170145475A1
(en)
|
2015-11-20 |
2017-05-25 |
Streck, Inc. |
Single spin process for blood plasma separation and plasma composition including preservative
|
WO2017123741A1
(en)
|
2016-01-12 |
2017-07-20 |
Institute For Myeloma & Bone Cancer Research |
Improved methods for monitoring immune status of a subject
|
WO2017214557A1
(en)
|
2016-06-10 |
2017-12-14 |
Counsyl, Inc. |
Nucleic acid sequencing adapters and uses thereof
|
WO2018002147A1
(en)
|
2016-06-30 |
2018-01-04 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Detection of borealin mutations for diagnosing thyroid dysgenesis
|
WO2018022890A1
(en)
|
2016-07-27 |
2018-02-01 |
Sequenom, Inc. |
Genetic copy number alteration classifications
|
WO2018022991A1
(en)
|
2016-07-29 |
2018-02-01 |
Streck, Inc. |
Suspension composition for hematology analysis control
|
US11854666B2
(en)
|
2016-09-29 |
2023-12-26 |
Myriad Women's Health, Inc. |
Noninvasive prenatal screening using dynamic iterative depth optimization
|
WO2018067517A1
(en)
|
2016-10-04 |
2018-04-12 |
Natera, Inc. |
Methods for characterizing copy number variation using proximity-litigation sequencing
|
US11274349B2
(en)
|
2016-11-08 |
2022-03-15 |
Cedars-Sinai Medical Center |
Methods for diagnosing cancer
|
US11279694B2
(en)
|
2016-11-18 |
2022-03-22 |
Sumitomo Dainippon Pharma Oncology, Inc. |
Alvocidib prodrugs and their use as protein kinase inhibitors
|
US10011870B2
(en)
|
2016-12-07 |
2018-07-03 |
Natera, Inc. |
Compositions and methods for identifying nucleic acid molecules
|
US10132797B2
(en)
|
2016-12-19 |
2018-11-20 |
Tolero Pharmaceuticals, Inc. |
Profiling peptides and methods for sensitivity profiling
|
CA3207879A1
(en)
|
2017-01-24 |
2018-08-02 |
Sequenom, Inc. |
Methods and processes for assessment of genetic variations
|
CA3049139A1
(en)
|
2017-02-21 |
2018-08-30 |
Natera, Inc. |
Compositions, methods, and kits for isolating nucleic acids
|
WO2018175907A1
(en)
|
2017-03-24 |
2018-09-27 |
Counsyl, Inc. |
Copy number variant caller
|
WO2018231944A1
(en)
|
2017-06-13 |
2018-12-20 |
Berenson James R |
Diagnostic, prognostic, and monitoring methods for solid tumor cancers
|
SK862017A3
(sk)
|
2017-08-24 |
2020-05-04 |
Grendar Marian Doc Mgr Phd |
Spôsob použitia fetálnej frakcie a chromozómovej reprezentácie pri určovaní aneuploidného stavu v neinvazívnom prenatálnom testovaní
|
WO2019055579A1
(en)
|
2017-09-12 |
2019-03-21 |
Tolero Pharmaceuticals, Inc. |
TREATMENT REGIME FOR CANCERS THAT ARE INSENSITIVE TO BCL-2 INHIBITORS USING THE MCL-1 ALVOCIDIB INHIBITOR
|
US20200299677A1
(en)
|
2017-10-27 |
2020-09-24 |
Juno Diagnostics, Inc. |
Devices, systems and methods for ultra-low volume liquid biopsy
|
WO2019229113A1
(en)
|
2018-05-30 |
2019-12-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Detection of tubb1 mutations for diagnosing thyroid dysgenesis
|
GB201810571D0
(en)
|
2018-06-27 |
2018-08-15 |
Cs Genetics Ltd |
Reagents and methods for the analysis of circulating microparticles
|
US11525159B2
(en)
|
2018-07-03 |
2022-12-13 |
Natera, Inc. |
Methods for detection of donor-derived cell-free DNA
|
MX2021006544A
(es)
|
2018-12-04 |
2021-07-07 |
Sumitomo Pharma Oncology Inc |
Inhibidores de cinasa dependiente de ciclina 9 (cdk9) y polimorfos de los mismos para uso como agentes para el tratamiento de cancer.
|
WO2020191326A1
(en)
|
2019-03-20 |
2020-09-24 |
Sumitomo Dainippon Pharma Oncology, Inc. |
Treatment of acute myeloid leukemia (aml) with venetoclax failure
|
GB201909325D0
(en)
|
2019-06-28 |
2019-08-14 |
Cs Genetics Ltd |
Reagents and methods for analysis for microparticles
|
GB202010970D0
(en)
|
2020-07-16 |
2020-09-02 |
Immunovia Ab |
Methods, arrays and uses thereof
|